Side Effect Management

Managing Immune-Related Adverse Events

Managing Immune-Related Adverse Events

An overview of the potential immune-related adverse events that can arise from treatment with checkpoint inhibitors.

Cancer Chemotherapeutics in Rheumatoid Arthritis: A Complex Connection

Cancer Chemotherapeutics in Rheumatoid Arthritis: A Complex Connection

Research is still needed to explore the association between cancer chemotherapeutics and rheumatoid arthritis.

Oncology Community Expresses Concern About Medicare Advantage Step-Therapy Policy

Oncology Community Expresses Concern About Medicare Advantage Step-Therapy Policy

More than 90 medical societies have called on the US government to reverse a policy allowing step therapy under Medicare Advantage.

Cancer-Related Fatigue May Predict Reduced Survival in Newly Diagnosed Multiple Myeloma

Cancer-Related Fatigue May Predict Reduced Survival in Newly Diagnosed Multiple Myeloma

Researchers investigated cancer-related fatigue in 16 patients with multiple myeloma who were treated with bortezomib, lenalidomide, or thalidomide.

Bacterial Conjunctivitis Drug Treatments

Bacterial Conjunctivitis Drug Treatments

Bacterial conjunctivitis treatment chart for topical medications.

Depression as a Side Effect: Exploring a Link Between Certain Cancer Treatments and Mental Health

Depression as a Side Effect: Exploring a Link Between Certain Cancer Treatments and Mental Health

Researchers are promoting physician and patient awareness about the potential tie between depression and certain therapies.

Is Paraneoplastic Granuloma Annulare Linked to Solid Organ Malignancies?

Is Paraneoplastic Granuloma Annulare Linked to Solid Organ Malignancies?

Recurrence of GA following cancer treatment should signal the possibility of cancer recurrence.

TNFi Not Linked to Increased Risk for Cancer Recurrence in Rheumatoid Arthritis

TNFi Not Linked to Increased Risk for Cancer Recurrence in Rheumatoid Arthritis

TNFi treatment is not associated with increased risk for cancer recurrence in patients with rheumatoid arthritis

High-Risk Breast Cancer Patients May Not Be Adherent to Heart Failure Monitoring

High-Risk Breast Cancer Patients May Not Be Adherent to Heart Failure Monitoring

There is a paucity of data regarding the cardiotoxicity and the monitoring adherence habits of patients undergoing treatment with trastuzumab or anthracyclines, commonly used therapies among patients with HER2-positive breast cancer.

Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE) Medications Chart

Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE) Medications Chart

List of medications indicated for the prophylaxis and/or treatment of deep vein thrombosis (DVT) / pulmonary embolism (PE) with usual adult dosage.

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs